AAV9 carrying the gigaxonin gene has been tested for treatment of Giant Axonal Neuropathy (GAN)11 and also provides expression of the SMN1 gene12 currently used by intravenous or intrathecal delivery for treatment of Spinal Muscular Atrophy (SMA). Here, SMN1 is linked to proximal spinal muscular atrophy.